All The Claims

What is claimed is:

1. A method of screening a preparation comprising hCG or an hCG chain or hCG chain or a derivative of hCG or of said alpha or -hCG chain, for anti-HIV activity comprising assaying said preparation for the ability to inhibit HIV replication or expression of HIV RNA or protein.
2. The method of claim 1 in which the preparation is assayed by a method comprising measuring HIV-1 p24 antigen levels in cultured hematopoietic cells acutely infected with HIV-1, which cells have been contacted with the preparation; and comparing the measured HIV-1 p24 antigen levels in the cells which have been contacted with the hCG preparation with said levels in cells not so contacted with the preparation, wherein a lower level in said contacted cells indicates that the preparation has anti-HIV activity.
4. The method of claim 1 in which the preparation includes a peptide comprising a -hCG (SEQ ID NO:2) segment selected from the group consisting of 41-54, 45-54, 47-53, 45-58, 41-53, 42-53, 43-53, 44-53, 44-57, 45-53, 46-53, 45-55, 45-56, 47-54, 47-56, 47-58, and 58-145 (SEQ ID NOS: 3-5, 18, 8-14, 16, 17, 19, 21, 22 and 24, respectively), wherein said segment is not flanked by natively occurring -hCG sequences.
5. The method of claim 1 in which the preparation includes a peptide (A) consisting essentially of a -hCG (SEQ ID NO:2) segment selected from the group consisting of 41-54, 45-54, 47-53, 45-58, 41-53, 42-53, 43-53, 44-53, 44-57, 45-53, 46-53, 45-55, 45-56, 47-54, 47-56, 47-58, and 58-145 (SEQ ID NOS: 3-5, 18, 8-14, 16, 17, 19, 21, 22 and 24, respectively); and (B) excluding -hCG (SEQ ID NO:2) amino acids contiguous to said segment.
6. The method of claim 1 in which the preparation includes a peptide comprising a -hCG (SEQ ID NO:2) segment selected from the group consisting of 41-54, 45-54, 47-53, 45-57, 45-58, 41-53, 42-53, 43-53, 44-53, 44-57, 45-53, 46-53, 45-54, 45-55, 45-56, 47-54, 47-56, 47-58, 48-145, or 58-145 (SEQ ID NOS: 3-6, 18, 8-17, and 19-24, respectively).
7. The method of claim 1 in which the preparation is assayed by a method comprising measuring the activity of a reporter gene product expressed from a construct in which the HIV-1 LTR is operably linked to said reporter gene, wherein said construct is present in cultured cells which have been contacted with the preparation; and comparing the measured expression of said reporter gene in the cells which have been contacted with the preparation with said levels in such cells not so contacted, wherein a lower level in said contacted cells indicates that the preparation has anti-HIV activity.
8. The method of claim 1 in which the preparation is assayed by a method comprising measuring HIV-1 derived RNA transcripts or HIV-1 antigen levels in HIV-1 transgenic mice administered the preparation; and comparing the measured transcript or antigen levels in the mice which have been administered the preparation with said levels in mice not so administered, wherein a lower level in said administered mice indicates that the preparation has anti-HIV activity.
9. The method of claim 1 in which the preparation is assayed by a method comprising measuring SIV p27 antigen levels in the peripheral blood mononuclear cells of SIV infected monkeys administered the preparation; and comparing the measured antigen levels in the monkeys which have been administered the preparation with said levels in monkeys not so administered, wherein a lower level in said administered monkeys indicates that the preparation has anti-HIV activity.
10. A method of treating or preventing HIV infection in a subject in need of such treatment or prevention, comprising administering to the subject an amount of a composition effective to treat or prevent HIV infection, wherein said composition (i) is administered by gene therapy, and (ii) includes a peptide comprising a -hCG (SEQ ID NO:2) segment selected from the group consisting of 41-54, 45-54, 47-53, 45-58, 41-53, 42-53, 43-53, 44-53, 44-57, 45-53, 46-53, 45-55, 45-56, 47-54, 47-56, 47-58, and 58-145 (SEQ ID NOS: 3-5, 18, 8-14, 16, 17, 19, 21, 22 and 24, respectively), wherein said segment is not flanked by natively occurring -hCG sequences.
11. A method of treating or preventing HIV infection in a subject in need of such treatment or prevention, comprising administering to the subject an amount of a composition effective to treat or prevent HIV infection, wherein said composition (i) is administered by gene therapy, and (ii) includes a peptide (A) consisting essentially of a -hCG (SEQ ID NO:2) segment selected from the group consisting of 41-54, 45-54, 47-53, 45-58, 41-53, 42-53, 43-53, 44-53, 44-57, 45-53, 46-53, 45-55, 45-56, 47-54, 47-56, 47-58, and 58-145 (SEQ ID NOS: 3-5, 18, 8-14, 16, 17, 19, 21, 22 and 24, respectively); and (B) excluding -hCG (SEQ ID NO:2) amino acids contiguous to said segment.
12. A method of treating or preventing HIV infection in a subject in need of such treatment or prevention, comprising administering to the subject an amount of a composition effective to treat or prevent HIV infection, wherein said composition (i) is administered by gene therapy, and (ii) includes a peptide comprising a -hCG (SEQ ID NO:2) segment selected from the group consisting of 41-54, 45-54, 47-53, 45-57, 45-58, 41-53, 42-53, 43-53, 44-53, 44-57, 45-53, 46-53, 45-54, 45-55, 45-56, 47-54, 47-56, 47-58, 48-145, or 58-145 (SEQ ID NOS: 3-6, 18, 8-17, and 19-24, respectively).
13. A pharmaceutical composition comprising a therapeutically effective amount of a purified nucleic acid encoding -hCG or a derivative of -hCG; and a pharmaceutically acceptable carrier.
14. The pharmaceutical composition of claim 13 in which the purified nucleic acid encodes a derivative of -hCG comprising a -hCG (SEQ ID NO:2) segment selected from the group consisting of 41-54, 45-54, 47-53, 45-58, 41-53, 42-53, 43-53, 44-53, 44-57, 45-53, 46-53, 45-55, 45-56, 47-54, 47-56, 47-58, and 58-145 (SEQ ID NOS: 3-5, 18, 8-14, 16, 17, 19, 21, 22 and 24, respectively) wherein said segment is not flanked by natively occurring -hCG sequences.
15. The pharmaceutical composition of claim 13 in which the purified nucleic acid encodes a derivative of -hCG comprising a -hCG (SEQ II) NO:2) segment selected from the group consisting of 41-54, 45-54, 47-53, 45-58, 41-53, 42-53, 43-53, 44-53, 44-57, 45-53, 46-53, 45-55, 45-56, 47-54, 47-56, 47-58, and 58-145 (SEQ ID NOS: 3-5, 18, 8-14, 16, 17, 19, 21, 22 and 24, respectively); and (B) excluding -hCG (SEQ ID NO:2) amino acids contiguous to said segment.
16. The pharmaceutical composition of claim 13 in which the purified nucleic acid encodes a derivative of -hCG comprising a -hCG (SEQ ID NO:2) segment selected from the group consisting of 41-54, 45-54, 47-53, 45-57, 45-58, 41-53, 42-53, 43-53, 44-53, 44-57, 45-53, 46-53, 45-54, 45-55, 45-56, 47-54, 47-56, 47-58, 48-145, or 58-145 (SEQ ID NOS: 3-6, 18, 8-17, and 19-24, respectively).
17. The pharmaceutical composition of claim 13 in which the nucleic acid is a nucleic acid vector.
18. A pharmaceutical composition comprising a recombinant cell containing a nucleic acid vector encoding -hCG or a derivative of -hCG; and a pharmaceutically acceptable carrier.
19. The pharmaceutical composition of claim 18 in which the nucleic acid encodes a derivative of -hCG comprising a -hCG (SEQ ID NO:2) segment selected from the group consisting of 41-54, 45-54, 47-53, 45-58, 41-53, 42-53, 43-53, 44-53, 44-57, 45-53, 46-53, 45-55, 45-56, 47-54, 47-56, 47-58, and 58-145 (SEQ ID NOS: 3-5, 18, 8-14, 16, 17, 19, 21, 22 and 24, respectively) wherein said segment is not flanked by natively occurring -hCG sequences.
20. The pharmaceutical composition of claim 18 in which the nucleic acid encodes a derivative of -hCG comprising a -hCG (SEQ ID NO:2) segment selected from the group consisting of 41-54, 45-54, 47-53, 45-58, 41-53, 42-53, 43-53, 44-53, 44-57, 45-53, 46-53, 45-55, 45-56, 47-54, 47-56, 47-58, and 58-145 (SEQ ID NOS: 3-5, 18, 8-14, 16, 17, 19, 21, 22 and 24, respectively); and (B) excluding -hCG (SEQ ID NO:2) amino acids contiguous to said segment.
21. The pharmaceutical composition of claim 18 in which the nucleic acid encodes a derivative of -hCG comprising a -hCG (SEQ ID NO:2) segment selected from the group consisting of 41-54, 45-54, 47-53, 45-57, 45-58, 41-53, 42-53, 43-53, 44-53, 44-57, 45-53, 46-53, 45-54, 45-55, 45-56, 47-54, 47-56, 47-58, 48-145, or 58-145 (SEQ ID NOS: 3-6, 18, 8-17, and 19-24, respectively).
22. The pharmaceutical composition of claim 18 in which the cell is a hematopoietic cell.
23. A nucleic acid that encodes a peptide, wherein said peptide is selected from the group consisting of:
(a) peptides comprising a -hCG (SEQ ID NO:2) segment selected from the group consisting of 41-54, 45-54, 47-53, 45-58, 41-53, 42-53, 43-53, 44-53, 44-57, 45-53, 46-53, 45-55, 45-56, 47-54, 47-56, 47-58, and 58-145 (SEQ ID NOS: 3-5, 18, 8-14, 16, 17, 19, 21, 22 and 24, respectively), wherein said segment is not flanked by natively occurring -hCG sequences;
(b) peptides consisting essentially of a -hCG (SEQ ID NO:2) segment selected from the group consisting of 41-54, 45-54, 47-53, 45-58, 41-53, 42-53, 43-53, 44-53, 44-57, 45-53, 46-53, 45-55, 45-56, 47-54, 47-56, 47-58, and 58-145 (SEQ ID NOS: 3-5, 18, 8-14, 16, 17, 19, 21, 22 and 24, respectively); and (B) excluding -hCG (SEQ ID NO:2) amino acids contiguous to said segment; and
(c) peptides comprising a -hCG (SEQ ID NO:2) segment selected from the group consisting of 41-54, 45-54, 47-53, 45-57, 45-58, 41-53, 42-53, 43-53, 44-53, 44-57, 45-53, 46-53, 45-54, 45-55, 45-56, 47-54, 47-56, 47-58, 48-145, or 58-145 (SEQ ID NOS: 3X, 18, 8-17, and 19-24, respectively).
24. A method of treating or preventing HIV infection in a human subject in need of such treatment or prevention comprising administering to the subject a therapeutic agent selected from the group consisting of:
(a) a recombinant cell as in claim 18; and
(b) a nucleic acid as in claim 23.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A hydromechanical transmission comprising:
a first planetary having first, second and third elements;
a second planetary having first, second and third elements connected to the first planetary;
a hydrostatic transmission connected to the first and second planetaries;
a first clutch connected to the first element of the second planetary and the third element of the first planetary;
a second clutch connected to the first element of the second planetary; wherein the clutches are sequentially engaged to create first and second forward operating modes.
2. The hydromechanical transmission of claim 1 further comprising:
an input connected to the third element of the second planetary;
an output connected to the third element of the first planetary; and
wherein the hydrostatic transmission has first and second hydrostatic units wherein the second hydrostatic unit is connected to the input and the third element of the second planetary.
3. The hydromechanical transmission of claim 1 further comprising a reverse clutch connected to the first element of the second planetary and a ground.
4. The hydromechanical transmission of claim 1 wherein the second clutch is connected to the third element of the second planetary.
5. The hydromechanical transmission of claim 1 further comprising a third clutch connected to the first planetary that is sequentially engaged in association with the first and second clutches to create a third forward operating mode.
6. The hydromechanical transmission of claim 1 further comprising an engine providing an input directly connected to the second planetary.
7. The hydromechanical transmission of claim 1 further comprising a third planetary having first, second and third elements wherein the first element of the third planetary is connected to the third element of the first planetary, the second element of the third planetary is connected to the second element of the first planetary with a third clutch and the third element of the third planetary is connected to an input.
8. A hydromechanical transmission comprising:
a hydrostatic transmission having first and second rotational shafts;
a first planetary having first, second and third elements wherein the first rotational shaft is connected to the second element of the first planetary;
said second rotational shaft connected to an input;
a second planetary having first, second and third elements wherein the third element of the second planetary is connected to the input;
a first, second and reverse clutch connected to the first element of the second planetary such that when selectively engaged the first, second and reverse clutches create first, second and third forward operating modes each having a continuous ratio.
9. The hydromechanical transmission of claim 8 further comprising an output connected to the third element of the first planetary.
10. The hydromechanical transmission of claim 8 wherein the first clutch is connected to the third element of the first planetary.
11. The hydromechanical transmission of claim 8 wherein the reverse clutch is connected with ground.
12. The hydromechanical transmission of claim 8 wherein the reverse clutch is connected to the third element of the first planetary with a reducing gear.
13. The hydromechanical transmission of claim 8 wherein the first element of the first planetary is connected to the second element of the second planetary.
14. The hydromechanical transmission of claim 8 wherein the second clutch is additionally connected to the third element of the second planetary.
15. The hydromechanical transmission of claim 8 further comprising:
a third planetary having first, second and third elements wherein the third element of the third planetary is connected to the third element of the second planetary, the first element of the third planetary is connected to the third element of the first planetary; and
a third clutch between the second element of the third planetary and the second element of the first planetary.
16. The hydromechanical transmission of claim 15 wherein there is a negative ratio between the first element of the third planetary and the third element of the first planetary, and a positive ratio between the second element of the third planetary and the second element of the first planetary.
17. The hydromechanical transmission of claim 8 wherein the hydrostatic transmission comprises a variable unit and a fixed unit wherein the variable unit changes displacement from a starting displacement to a negative of the starting displacement in the first, second and third forward operating modes.
18. The hydromechanical transmission of claim 17 wherein the variable unit does not change displacement during a mode change.
19. A hydromechanical transmission comprising:
an input having an input center line and an output having an output center line parallel to the input centerline;
a first planetary having a first, second and third elements wherein the output is connected to the first planetary;
a second planetary located on the input center line and having first, second and third elements wherein the third element of the second planetary is connected to the input; and
first, second and reverse clutches connected to the second planetary such that when sequentially engaged first, second and third forward operating modes with continuous ratios are created.
20. The hydromechanical transmission of claim 19 wherein the second element of the second planetary is connected to the first element of the first planetary.
21. The hydromechanical transmission of claim 19 wherein the first, second and reverse clutches are adjacent.
22. The hydromechanical transmission of claim 19 wherein the input extends through the transmission for a power takeoff.
23. The hydromechanical transmission of claim 19 wherein the output extends through the transmission to provide drive at both ends of the transmission.
24. The hydromechanical transmission of claim 19 wherein at least one of the elements of the first and second planetaries is a sun gear having a speed that is greater than speeds of the other elements.
25. The hydromechanical transmission of claim 19 wherein the reverse clutch connects the third element of the first planetary with the first element of the second planetary and a reduction gear.
26. The hydromechanical transmission of claim 19 wherein a third planetary is located on the output center line and has first, second and third elements wherein the third element of the third planetary is connected to the input, the second element of the third planetary is connected to the second element of the first planetary with a third clutch and the first element of the third planetary is connected to the third element of the first planetary.

What is claimed is:

1. A compound of the formula
182
wherein
R1 is selected from the group consisting of C(O)R3, C(O)OR4, and SO2R5
wherein R3 is selected from the group consisting of alkyl and cycloalkyl, R4 is selected from the group consisting of alkyl and cycloalkyl, R5 is selected from the group consisting of alkyl, cycloalkyl, and fluorinated alkyl;

R2 is from 1 to 3 substituents independently selected from the group consisting of hydrogen, hydroxy, trisubstituted silyloxy, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkoxy, substituted alkoxy, cycloalkoxy, substituted cycloalkoxy, cycloalkyl, substituted cycloalkyl, halogen, cyano, nitro, phenyl, substituted phenyl, pyridyloxy, thiophenoxy, substituted thiophenoxy, phenylsulfinyl, substituted phenylsulfinyl, phenylsulfonyl, substituted phenylsulfonyl, benzoyl, substituted benzoyl, phenoxy, and substituted phenoxy; or
two R2 substituents are taken together, on adjacent positions, to form a fused cycloalkyl or a methylenedioxy ring, and one R2 substituent is selected from the group consisting of hydrogen, hydroxy, trisubstituted silyloxy, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkoxy, substituted alkoxy, cycloalkoxy, substituted cycloalkoxy, cycloalkyl, substituted cycloalkyl, halogen, cyano, nitro, phenyl, substituted phenyl, pyridyloxy, thiophenoxy, substituted thiophenoxy, phenylsulfinyl, substituted phenylsulfinyl, phenylsulfonyl, substituted phenylsulfonyl, benzoyl, substituted benzoyl, phenoxy, and substituted phenoxy;
R6 is from 1 to 2 substituents independently selected from the group consisting of hydrogen, alkyl, alkoxy, trifluoromethyl, halogen, phenoxy, and substituted phenoxy;
X is selected from the group consisting of a bond, CH2, CHR7, and CH2CH2 wherein R7 is lower alkyl;
Y is selected from the group consisting of a bond, CH2, CHR8, CH2CH2, CHR9CH2, and CH2CHR9 wherein R8 is lower alkyl and R9 is lower alkyl;
and the pharmaceutically acceptable salts thereof and the pyridyl N-oxides thereof.
2. A compound according to claim 1 wherein the pyridyl moiety is attached to X at the 3-position.
3. A compound according to claim 2 wherein R1 is SO2R5.
4. A compound according to claim 1 wherein the pyridyl moiety is attached to X at the 4-position.
5. A compound according to claim 2 wherein R1 is C(O)OR4.
6. A compound according to claim 3 or 5 wherein R2 is from 1 to 3 substituents independently selected from the group consisting of hydrogen, hydroxy, trisubstituted silyloxy, alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkoxy, substituted alkoxy, cycloalkoxy, substituted cycloalkoxy, cycloalkyl, substituted cycloalkyl, halogen, cyano, nitro, phenyl, substituted phenyl, pyridyloxy, thiophenoxy, substituted thiophenoxy, phenylsulfinyl, substituted phenylsulfinyl, phenylsulfonyl, substituted phenylsulfonyl, benzoyl, substituted benzoyl, phenoxy, and substituted phenoxy.
7. A compound according to claim 6 wherein R2 is selected from group consisting of substituted alkyl, phenyl, substituted phenyl, thiophenoxy, substituted thiophenoxy, phenoxy, and substituted phenoxy.
8. A compound according to claim 7 wherein the substituted alkyl is selected from the group consisting of benzyl and substituted benzyl
9. A compound according to claim 7 wherein R2 is selected from group consisting of phenyl and substituted phenyl.
10. A compound according to claim 7 wherein R2 is selected from group consisting of phenoxy and substituted phenoxy.
11. A compound according to any of claims 1-10 wherein at least one of the R2 substituents is attached in the 3-position.
12. A compound according to any of claims 1-10 wherein at least one of the R2 substituents is attached in the 4-position.
13. A compound according to claim 1 wherein at least 1 R2 is substituted benzyl, substituted phenyl, or substituted phenoxy and one of the substituents is selected from the group consisting of alkyl, substituted alkyl, alkoxy, substituted alkoxy, halogen, cyano, amido, and substituted amido.
14. A compound according to any one of claims 1-13 wherein X is a CH2.
15. A compound according to any one of claims 1-13 wherein Y is a bond.
16. A compound according to any one of claims 1-13 wherein X is a CH2 and Y is bond.
17. A compound of claim 1 selected from the group consisting of N-(3-(2-Methoxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine, N-(3-(2-Benzyloxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine, N-(4-Phenoxy)phenyl)-N-(ethylsulfonyl)-2-(pyrid-3-yl)ethylamine, N-(4-Phenoxy)phenylethyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(4-Phenoxy)phenylmethyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(iso-propylsulfonyl)pyrid-3-ylmethylamine, N-(2-(Phenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2-Methoxyphenoxy)-3-chlorophenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2,6-Dimethoxyphenoxy)-3-chlorophenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2-Benzyloxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2-Methoxyphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2-Methopxyphenoxy)phenyl)-N-(cyclopropylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2-Methoxyphenoxy)-3-chlorophenyl)-N-ethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2-Methoxyphenoxy)-3-chlorophenyl)-N-cyclopropylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2-Methoxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2-Ethoxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2-Ethoxyphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2-Ethoxyphenoxy)phenyl)-N-(cyclopropylsulfonyl)pyrid-3-ylmethylamine, N-(3-(2-Methoxyphenoxy)phenyl)-N-(cyclopropylsulfonyl)pyrid-3-ylmethylamine, N-(3-(2-Methoxyphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2-Hydroxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine, N-(3-(2-Hydroxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(methylsulfonyl)pyrid-2-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(ethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(butylsulfonyl)pyrid-2-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(methoxycarbonyl)pyrid-2-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(methylsulfonyl)pyrid-3-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(butylsulfonyl)pyrid-3-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(methoxycarbonyl)pyrid-3-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(methylsulfonyl)pyrid-4-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(ethylsulfonyl)pyrid-4-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(butylsulfonyl)pyrid-4-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-4-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(methoxycarbonyl)pyrid-4-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(propionyl)pyrid-2-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(cyclopentylcarbonyl propionyl)pyrid-2-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(propionyl)pyrid-3-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(cyclopentylcarbonyl)pyrid-3-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(propionyl)pyrid-4-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(cyclopentylcarbonyl)pyrid-4-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(trifluoromethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(trifluoromethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(trifluoromethylsulfonyl)pyrid-4-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(propylsulfonyl)pyrid-2-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(propylsulfonyl)pyrid-3-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(propylsulfonyl)pyrid-4-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(2-methylpropionyl)pyrid-2-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(2-methylpropionyl)pyrid-3-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(2-methylpropionyl)pyrid-4-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(acetyl)pyrid-2-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(acetyl)pyrid-3-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(acetyl)pyrid-4-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(cyclopropylcarbonyl)pyrid-2-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(cyclopropylcarbonyl)pyrid-3-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(cyclopropylcarbonyl)pyrid-4-ylmethylamine, N-(4-(4-Benzyloxyphenoxy)phenyl)-N-(cyclopropylcarbonyl)pyrid-3-ylmethylamine, N-(4-(4-Cyclohexylphenoxy)phenyl)-N-(cyclopropylcarbonyl)pyrid-3-ylmethylamine, N-(4-(4-Benzylphenoxy)phenyl)-N-(cyclopropylcarbonyl)pyrid-3-ylmethylamine, N-(4-(4-Thiophenoxyphenoxy)phenyl)-N-(cyclopropylcarbonyl)pyrid-3-ylmethylamine, N-(4-(4-Benzyloxyphenoxy)phenyl)-N-(methylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Cyclohexylphenoxy)phenyl)-N-(methylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Benzylphenoxy)phenyl)-N-(methylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Thiophenoxyphenoxy)phenyl)-N-(methylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Benzyloxyphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Cyclohexylphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Benzylphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Thiophenoxyphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Benzyloxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Cyclohexylphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Benzylphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Thiophenoxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Benzyloxyphenoxy)phenyl)-N-(trifluoromethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Cyclohexylphenoxy)phenyl)-N-(trifluoromethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Benzylphenoxy)phenyl)-N-(trifluoromethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Thiophenoxyphenoxy)phenyl)-N-(trifluoromethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Benzyloxyphenoxy)phenyl)-N-(propylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Cyclohexylphenoxy)phenyl)-N-(propylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Benzylphenoxy)phenyl)-N-(propylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Thiophenoxyphenoxy)phenyl)-N-(propylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Benzyloxyphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(4-Cyclohexylphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(4-Benzylphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(4-Thiophenoxyphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(4-Benzyloxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(4-Cyclohexylphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(4-Benzylphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(4-Thiophenoxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(Pentoxy)phenyl)-N-(cyclopropylcarbonyl)pyrid-3-ylmethylamine, N-(4-(3,4-Methylenedioxyphenoxy)phenyl)-N-(cyclopropylcarbonyl)pyrid-3-ylmethylamine, N-(4-(Methoxy)phenyl)-N-(cyclopropylcarbonyl)pyrid-3-ylmethylamine, N-(4-(5,6,7,8-Tetrahydronaphth-2-yloxy)phenyl)-N-(cyclopropylcarbonyl)pyrid-3-ylmethylamine, N-(4-(4-Cyclohexyloxy)phenyl)-N-(cyclopropylcarbonyl)pyrid-3-ylmethylamine, N-(4-(4-Pyrid-2-yloxyphenoxy)phenyl)-N-(cyclopropylcarbonyl)pyrid-3-ylmethylamine, N-(4-(Pentoxy)phenyl)-N-(methylsulfonyl)pyrid-3-ylmethylamine, N-(4-(3,4-Methylenedioxyphenoxy)phenyl)-N-(methylsulfonyl)pyrid-3-ylmethylamine, N-(4-(Methoxy)phenyl)-N-(methylsulfonyl)pyrid-3-ylmethylamine, N-(4-(5,6,7,8-Tetrahydronaphth-2-yloxy)phenyl)-N-(methylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Cyclohexyloxy)phenyl)-N-(methylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Pyrid-2-yloxyphenoxy)phenyl)-N-(methylsulfonyl)pyrid-3-ylmethylamine, N-(4-(Pentoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(3,4-Methylenedioxyphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(Methoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(5,6,7,8-Tetrahydronaphth-2-yloxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Cyclohexyloxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Pyrid-2-yloxyphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(Pentoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(3,4-Methylenedioxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(Methoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(5,6,7,8-Tetrahydronaphth-2-yloxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Cyclohexyloxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Pyrid-2-yloxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(Pentoxy)phenyl)-N-(trifluoromethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(3,4-Methylenedioxyphenoxy)phenyl)-N-(trifluoromethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(Methoxy)phenyl)-N-(trifluoromethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(5,6,7,8-Tetrahydronaphth-2-yloxy)phenyl)-N-(trifluoromethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Cyclohexyloxy)phenyl)-N-(trifluoromethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Pyrid-2-yloxyphenoxy)phenyl)-N-(trifluoromethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(Pentoxy)phenyl)-N-(propylsulfonyl)pyrid-3-ylmethylamine, N-(4-(3,4-Methylenedioxyphenoxy)phenyl)-N-(propylsulfonyl)pyrid-3-ylmethylamine, N-(4-(Methoxy)phenyl)-N-(propylsulfonyl)pyrid-3-ylmethylamine, N-(4-(5,6,7,8-Tetrahydronaphth-2-yloxy)phenyl)-N-(propylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Cyclohexyloxy)phenyl)-N-(propylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Pyrid-2-yloxyphenoxy)phenyl)-N-(propylsulfonyl)pyrid-3-ylmethylamine, N-(4-(Pentoxy)phenyl)-N-(ethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(3,4-Methylenedioxyphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(Methoxy)phenyl)-N-(ethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(5,6,7,8-Tetrahydronaphth-2-yloxy)phenyl)-N-(ethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(4-Cyclohexyloxy)phenyl)-N-(ethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(4-Pyrid-2-yloxyphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(Pentoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(3,4-Methylenedioxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(Methoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(5,6,7,8-Tetrahydronaphth-2-yloxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(4-Cyclohexyloxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(4-Pyrid-2-yloxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-2-ylmethylamine, N-(3-(Phenoxy)phenyl)-N-(cyclopropylcarbonyl)pyrid-3-ylmethylamine, N-(2-(Phenoxy)phenyl)-N-(cyclopropylcarbonyl)pyrid-3-ylmethylamine, N-(4-(4-Chlorophenoxy)phenyl)-N-(cyclopropylcarbonyl)pyrid-3-ylmethylamine, N-(4-(3-Trifluoromethylphenoxy)phenyl)-N-(cyclopropylcarbonyl)pyrid-3-ylmethylamine, N-(4-(2-Methoxyphenoxy)phenyl)-N-(cyclopropylcarbonyl)pyrid-3-ylmethylamine, N-(4-(4-Cyanophenoxy)phenyl)-N-(cyclopropylcarbonyl)pyrid-3-ylmethylamine, N-(4-(2,4-Difluorophenoxy)phenyl)-N-(cyclopropylcarbonyl)pyrid-3-ylmethylamine, N-(3-(Phenoxy)phenyl)-N-(methylsulfonyl)pyrid-3-ylmethylamine, N-(2-(Phenoxy)phenyl)-N-(methylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Chlorophenoxy)phenyl)-N-(methylsulfonyl)pyrid-3-ylmethylamine, N-(4-(3-Trifluoromethylphenoxy)phenyl)-N-(methylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2-Methoxyphenoxy)phenyl)-N-(methylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Cyanophenoxy)phenyl)-N-(methylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2,4-Difluorophenoxy)phenyl)-N-(methylsulfonyl)pyrid-3-ylmethylamine, N-(3-(Phenoxy)phenyl)-N-(ethylsulfonyl)pyrid-2-ylmethylamine, N-(2-(Phenoxy)phenyl)-N-(ethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(4-Chlorophenoxy)phenyl)-N-(ethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(3-Trifluoromethylphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(2-Methoxyphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(4-Cyanophenoxy)phenyl)-N-(ethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(2,4-Difluorophenoxy)phenyl)-N-(ethylsulfonyl)pyrid-2-ylmethylamine, N-(3-(Phenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-2-ylmethylamine, N-(2-(Phenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(4-Chlorophenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(3-Trifluoromethylphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(2-Methoxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(4-Cyanophenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(2,4-Difluorophenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-2-ylmethylamine, N-(3-(Phenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(2-(Phenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Chlorophenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(3-Trifluoromethylphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2-Methoxyphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Cyanophenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2,4-Difluorophenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(3-(Phenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine, N-(2-(Phenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Chlorophenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(3-Trifluoromethylphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2-Methoxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Cyanophenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2,4-Difluorophenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine, N-(3-(Phenoxy)phenyl)-N-(trifluoromethylsulfonyl)pyrid-3-ylmethylamine, N-(2-(Phenoxy)phenyl)-N-(trifluoromethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Chlorophenoxy)phenyl)-N-(trifluoromethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(3-Trifluoromethylphenoxy)phenyl)-N-(trifluoromethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2-Methoxyphenoxy)phenyl)-N-(trifluoromethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Cyanophenoxy)phenyl)-N-(trifluoromethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2,4-Difluorophenoxy)phenyl)-N-(trifluoromethylsulfonyl)pyrid-3-ylmethylamine, N-(3-(Phenoxy)phenyl)-N-(propylsulfonyl)pyrid-3-ylmethylamine, N-(2-(Phenoxy)phenyl)-N-(propylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Chlorophenoxy)phenyl)-N-(propylsulfonyl)pyrid-3-ylmethylamine, N-(4-(3-Trifluoromethylphenoxy)phenyl)-N-(propylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2-Methoxyphenoxy)phenyl)-N-(propylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Cyanophenoxy)phenyl)-N-(propylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2,4-Difluorophenoxy)phenyl)-N-(propylsulfonyl)pyrid-3-ylmethylamine, N-(2-Chloro-5-methyl-4-(phenoxy)phenyl)-N-(cyclopropylcarbonyl)pyrid-3-ylmethylamine, N-(3-Chloro-4-(phenoxy)phenyl)-N-(cyclopropylcarbonyl)pyrid-3-ylmethylamine, N-(2-Methyl-4-(phenoxy)phenyl)-N-(cyclopropylcarbonyl)pyrid-3-ylmethylamine, N-(3-Trifluoromethyl-4-(phenoxy)phenyl)-N-(cyclopropylcarbonyl)pyrid-3-ylmethylamine, N-(4-(4-Nitrophenoxy)phenyl)-N-(cyclopropylcarbonyl)pyrid-3-ylmethylamine, N-(2-Chloro-5-methyl-4-(phenoxy)phenyl)-N-(methylsulfonyl)pyrid-3-ylmethylamine, N-(3-Chloro-4-(phenoxy)phenyl)-N-(methylsulfonyl)pyrid-3-ylmethylamine, N-(2-Methyl-4-(phenoxy)phenyl)-N-(methylsulfonyl)pyrid-3-ylmethylamine, N-(3-Trifluoromethyl-4-(phenoxy)phenyl)-N-(methylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Nitrophenoxy)phenyl)-N-(methylsulfonyl)pyrid-3-ylmethylamine, N-(2-Chloro-5-methyl-4-(phenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(3-Chloro-4-(phenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(2-Methyl-4-(phenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(3-Trifluoromethyl-4-(phenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Nitrophenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(2-Chloro-5-methyl-4-(phenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine, N-(3-Chloro-4-(phenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine, N-(2-Methyl-4-(phenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine, N-(3-Trifluoromethyl-4-(phenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Nitrophenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine, N-(2-Chloro-5-methyl-4-(phenoxy)phenyl)-N-(trifluoromethylsulfonyl)pyrid-3-ylmethylamine, N-(3-Chloro-4-(phenoxy)phenyl)-N-(trifluoromethylsulfonyl)pyrid-3-ylmethylamine, N-(2-Methyl-4-(phenoxy)phenyl)-N-(trifluoromethylsulfonyl)pyrid-3-ylmethylamine, N-(3-Trifluoromethyl-4-(phenoxy)phenyl)-N-(trifluoromethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Nitrophenoxy)phenyl)-N-(trifluoromethylsulfonyl)pyrid-3-ylmethylamine, N-(2-Chloro-5-methyl-4-(phenoxy)phenyl) N-(propylsulfonyl)pyrid-3-ylmethylamine, N-(3-Chloro-4-(phenoxy)phenyl)-N-(propylsulfonyl)pyrid-3-ylmethylamine, N-(2-Methyl-4-(phenoxy)phenyl)-N-(propylsulfonyl)pyrid-3-ylmethylamine, N-(3-Trifluoromethyl-4-(phenoxy)phenyl)-N-(propylsulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Nitrophenoxy)phenyl)-N-(propylsulfonyl)pyrid-3-ylmethylamine, N-(2-Chloro-5-methyl-4-(phenoxy)phenyl)-N-(ethylsulfonyl)pyrid-2-ylmethylamine, N-(3-Chloro-4-(phenoxy)phenyl)-N-(ethylsulfonyl)pyrid-2-ylmethylamine, N-(2-Methyl-4-(phenoxy)phenyl)-N-(ethylsulfonyl)pyrid-2-ylmethylamine, N-(3-Trifluoromethyl-4-(phenoxy)phenyl)-N-(ethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(4-Nitrophenoxy)phenyl)-N-(ethylsulfonyl)pyrid-2-ylmethylamine, N-(2-Chloro-5-methyl-4-(phenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-2-ylmethylamine, N-(3-Chloro-4-(phenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-2-ylmethylamine, N-(2-Methyl-4-(phenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-2-ylmethylamine, N-(3-Trifluoromethyl-4-(phenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(4-Nitrophenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)-6-methoxypyrid-3-ylmethylamine, N-(3-(Phenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)-6-methoxypyrid-3-ylmethylamine, N-(4-(2-Methoxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)-6-methoxypyrid-3-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(ethylsulfonyl)-6-methoxypyrid-3-ylmethylamine, N-(3-(Phenoxy)phenyl)-N-(ethylsulfonyl)-6-methoxypyrid-3-ylmethylamine, N-(4-(2-Methoxyphenoxy)phenyl)-N-(ethylsulfonyl)-6-methoxypyrid-3-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)-6-methylpyrid-3-ylmethylamine, N-(3-(Phenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)-6-methylpyrid-3-ylmethylamine, N-(4-(2-Methoxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)-6-methylpyrid-3-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(ethylsulfonyl)-6-methylpyrid-3-ylmethylamine, N-(3-(Phenoxy)phenyl)-N-(ethylsulfonyl)-6-methylpyrid-3-ylmethylamine, N-(4-(2-Methoxyphenoxy)phenyl)-N-(ethylsulfonyl)-6-methylpyrid-3-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)-6-(4-chlorophenoxy)pyrid-3-ylmethylamine, N-(3-(Phenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)-6-(4-chlorophenoxy)pyrid-3-ylmethylamine, N-(4-(2-Methoxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)-6-(4-chlorophenoxy)pyrid-3-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(ethylsulfonyl)-6-(4-chlorophenoxy)pyrid-3-ylmethylamine, N-(3-(Phenoxy)phenyl)-N-(ethylsulfonyl)-6-(4-chlorophenoxy)pyrid-3-ylmethylamine, N-(4-(2-Methoxyphenoxy)phenyl)-N-(ethylsulfonyl)-6-(4-chlorophenoxy)pyrid-3-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)-2-chloropyrid-3-ylmethylamine, N-(3-(Phenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)-2-chloropyrid-3-ylmethylamine, N-(4-(2-Methoxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)-2-chloropyrid-3-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(ethylsulfonyl)-2-chloropyrid-3-ylmethylamine, N-(3-(Phenoxy)phenyl)-N-(ethylsulfonyl)-2-chloropyrid-3-ylmethylamine, N-(4-(2-Methoxyphenoxy)phenyl)-N-(ethylsulfonyl)-2-chloropyrid-3-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)-2-phenoxypyrid-3-ylmethylamine, N-(3-(Phenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)-2-phenoxypyrid-3-ylmethylamine, N-(4-(2-Methoxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)-2-phenoxypyrid-3-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(ethylsulfonyl)-2-phenoxypyrid-3-ylmethylamine, N-(3-(Phenoxy)phenyl)-N-(ethylsulfonyl)-2-phenoxypyrid-3-ylmethylamine, N-(4-(2-Methoxyphenoxy)phenyl)-N-(ethylsulfonyl)-2-phenoxypyrid-3-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)-6-chloropyrid-3-ylmethylamine, N-(3-(Phenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)-6-chloropyrid-3-ylmethylamine, N-(4-(2-Methoxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)-6-chloropyrid-3-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(ethylsulfonyl)-6-chloropyrid-3-ylmethylamine, N-(3-(Phenoxy)phenyl)-N-(ethylsulfonyl)-6-chloropyrid-3-ylmethylamine, N-(4-(2-Methoxyphenoxy)phenyl)-N-(ethylsulfonyl)-6-chloropyrid-3-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)-2-chloro-6-methylpyrid-3-ylmethylamine, N-(3-(Phenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)-2-chloro-6-methylpyrid-3-ylmethylamine, N-(4-(2-Methoxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)-2-chloro-6-methylpyrid-3-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(ethylsulfonyl)-2-chloro-6-methylpyrid-3-ylmethylamine, N-(3-(Phenoxy)phenyl)-N-(ethylsulfonyl)-2-chloro-6-methylpyrid-3-ylmethylamine, N-(4-(2-Methoxyphenoxy)phenyl)-N-(ethylsulfonyl)-2-chloro-6-methylpyrid-3-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(cyclopropylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2-Methoxyphenoxy)phenyl)phenyl)-N-(cyclopropylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2-Methoxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-4-ylmethylamine, N-(4-(2-Methoxyphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-4-ylmethylamine, N-(4-(2,6-Dimethoxyphenoxy)phenyl)-N-(cyclopropylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2,6-Dimethoxyphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2,6-Dimethoxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2,6-Dimethoxyphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(2,6-Dimethoxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(2,6-Dimethoxyphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-4-ylmethylamine, N-(4-(2,6-Dimethoxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-4-ylmethylamine, N-(4-(2-Phenoxy-6-chloro)phenylmethyl)-N-(cyclopropylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2-Phenoxy-6-chloro)phenylmethyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2-Phenoxy-6-chloro)phenylmethyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2-Phenoxy-6-chloro)phenylmethyl)-N-(ethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(2-Phenoxy-6-chloro)phenylmethyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(2-Phenoxy-6-chloro)phenylmethyl)-N-(ethylsulfonyl)pyrid-4-ylmethylamine, N-(4-(2-Phenoxy-6-chloro)phenylmethyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-4-ylmethylamine, N-(4-(2,6-Dichlorophenoxy)phenyl)-N-(cyclopropylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2,6-Dichlorophenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2,6-Dichlorophenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2,6-Dichlorophenoxy)phenyl)-N-(ethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(2,6-Dichlorophenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(2,6-Dichlorophenoxy)phenyl)-N-(ethylsulfonyl)pyrid-4-ylmethylamine, N-(4-(2,6-Dichlorophenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-4-ylmethylamine, N-(4-(2-Isopropoxyphenoxy)phenyl)-N-(cyclopropylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2-Isopropoxyphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2-Isopropoxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2-Isopropoxyphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(2-Isopropoxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(2-Isopropoxyphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-4-ylmethylamine, N-(4-(2-Isopropoxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-4-ylmethylamine, N-(4-(2-Fluoro-6-methoxyphenoxy)phenyl)-N-(cyclopropylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2-Fluoro-6-methoxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2-Fluoro-6-methoxyphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2-Fluoro-6-methoxyphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(2-Fluoro-6-methoxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(2-Fluoro-6-methoxyphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-4-ylmethylamine, N-(4-(2-Fluoro-6-methoxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-4-ylmethylamine, N-(4-(2-Trfiluoromethylphenoxy)phenyl)-N-(cyclopropylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2-Trfiluoromethylphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2-Trfiluoromethylphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2-Trfiluoromethylphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(2-Trfiluoromethylphenoxy)phenyl)-N-(2,2,2-trifluroethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(2-Trfiluoromethylphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-4-ylmethylamine, N-(4-(2-Trfiluoromethylphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-4-ylmethylamine, N-(4-(2-Isopropyl-5-methylphenoxy)phenyl)-N-(cyclopropylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2-Isopropyl-5-methylphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2-Isopropyl-5-methylphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2-Isopropyl-5-methylphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(2-Isopropyl-5-methylphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(2-Isopropyl-5-methylphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-4-ylmethylamine, N-(4-(2-Isopropyl-5-methylphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-4-ylmethylamine, N-(4-(2-Cyclopentylphenoxy)phenyl)-N-(cyclopropylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2-Cyclopentylphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2-Cyclopentylphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(2-Cyclopentylphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(2-Cyclopentylphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-2-ylmethylamine, N-(4-(2-Cyclopentylphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-4-ylmethylamine, N-(4-(2-Cyclopentylphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-4-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)-2-(2,2,2-trifluoroethoxy)pyrid-3-ylmethylamine, N-(4-(2-Methoxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)-2-(2,2,2-trifluoroethoxy)pyrid-3-ylmethylamine, N-(4-(2-Isopropoxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)-2-(2,2,2-trifluoroethoxy)pyrid-3-ylmethylamine, N-(4-(2-Fluoro-6-methoxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)-2-(2,2,2-trifluoroethoxy)pyrid-3-ylmethylamine, N-(4-(4-Hydroxyphenoxy)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(2-Methoxyphenylsulfinyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(2,4-Difluorophenoxy)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(2-Methoxyphenoxy)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(3-Benzyloxyphenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(3-Hydroxyphenoxy)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(4-t-Butyldimethylsilyloxy)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-Hydroxyphenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-t-Butyldimethylsilyloxy)phenyl)-N-(2,2,2-trifluoro ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-Hdydroxyphenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(Phenoxy)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)-1-oxypyrid-3-ylmethylamine, N-(4-(2-Cyanophenoxy)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(2-Cyanophenoxy)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(2-Methoxyphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(3-(2-phenylphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(4-Bromophenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(2-Fluorophenoxy)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(3-Fluorophenoxy)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Fluorophenoxy)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(2,4-Difluorophenoxy)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(2-trifluoromethoxyphenoxy)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(4-fluoro-2-methyphenoxyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(4-trifluoromethoxyphenoxy)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(2,4-dimethylphenoxy)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(4-methylphenoxy)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(4-isopropylphenoxy)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(4-t-butylphenoxy)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(2-methylphenoxy)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(2-Amidophenoxy)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(3-Methylslulfinylphenoxy)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(4-t-butyl-2-fluoro phenoxy)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(4-fluoro-2-n-propyl phenoxy)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Carbonylmethoxyphenoxy)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(4-amidomethylphenoxy)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(3-t-butylphenoxy)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(2-methoxyphenoxy)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(3-methylphenoxy)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(2-chlorophenoxy)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Amidophenoxy)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(2-methylphenoxy)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Methylsulfonylphenoxy)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(2-(prop-2-yl)phenoxy)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(2-ethylphenoxy)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Sulfonylamidophenoxy)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(2,4-Difluorophenoxy)phenyl)-N-(ethanesulfonyl)-1-pyrid-3-ylethylamine, N-((3-Benzyloxyphenoxy)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(Bromophenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(3-(2-fluorophenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(3-(3-fluorophenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(3-(4-fluorophenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(3-(2,4-difluorophenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(3-(2-ethoxyphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(3-(2-phenyl phenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(3-(4-trifluoromethoxyphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(3-(4-methylphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(3-(2-methyl-4-fluorophenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(3-(2-trifluoromethoxyphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(3-(4-Amidomethylphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(3-(4-Amidophenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(3-(4-Methylsulfonylphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(3-(4-Methylsulfinylphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(3-(4-t-butylphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(3-(3-methylphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(3-(2-n-propyl-4-fluorophenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(3-(2-chlorophenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(3-(2-methylphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(3-(phenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(3-(4-carbonylmethoxyphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(3-(3-t-butylphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(3-(4-fluoro-2-(3-hydroxy-3-methylbutyl)phenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(3-(2-fluoro-4-t-butylphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(3-(4-Cabonylmethoxymethylphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(3-(3-Amidophenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(3-(2,4-diflurophenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(3-(2,4,6-triflurophenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(3-(2-(prop-2-yl)phenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(3-(2-ethylphenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(3-(4-Sulfonylamidophenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(3-(phenoxy)phenyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(4-(3-Methoxybenzyloxy)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(2-Fluorophenoxy)phenyl)-N-(2,2,2-trifluorethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(2-Methylphenoxy)phenyl)-N-(2,2,2-trifluorethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(4-Carboxymethylphenoxy)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(2-Fluoro-4-methylphenoxy)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(2-methoxy-phenylsulfanyl))phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(2-methoxy-phenylsulfanyl))phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(2-methoxy-phenoxy))phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(2-benzyloxy-phenoxy))phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(4-fluoro-2-methoxy-phenoxy))phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(4-fluoro-2-methoxy-phenoxy))phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(2-bromo-phenoxy))phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(2,3-dimethoxy-phenoxy))phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(2-chloro-phenoxy))phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(2-chloro-6-methyl-phenoxy))phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(2-isopropoxy-phenoxy))phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-fluoro-5-(2-methoxy-phenoxy))phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(3-fluoro-5-(2-methoxy-phenoxy))phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(2-methoxy-phenoxy))phenyl)-N-(3,3,3-trifluoropropanesulfonyl)pyrid-3-ylmethylamine, N-(3-(2-bromo-phenoxy))phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(2,3-dimethoxy-phenoxy))phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(2-chloro-phenoxy))phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(2-chloro-phenoxy))phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(2-chloro-6-methyl-phenoxy))phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(2-isopropoxy-phenoxy))phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(Benzyl)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(Benzyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-Methoxycarbonylphenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(3-Methoxycarbonylphenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(Hydoxymethyl)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(Hydroxymethyl)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(-Hydroxybenzyl)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(-hydroxybenzyl)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(4–hydroxy-2-methylsulfanylbenzyl)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(3–hydroxy-4-methylsulfanylbenzyl)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(4–hydroxy-2-methoxybenzyl)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(3–hydroxy-2-methoxybenzyl)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(4–hydroxy-3,4-difluorobenzyl)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(-hydroxy-3,4-difluorobenzyl)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(4–hydroxy-2-phenylbenzyl)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(3–hydroxy-2-phenylbenzyl)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(1-hydroxy-1-(5-methylpyrid-2-yl)methyl)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(4–hydroxy-2-trifluoromethylbenzyl)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(3–hydroxy-2-fluorobenzyl)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(4–hydroxy-2-fluorobenzyl)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(4–hydroxy-3-fluorobenzyl))phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(Benzyl)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(2-methylsulfanyl benzyl)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(4-methylsulfanylbenzyl)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(4-methoxybenzyl)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(4-methoxybenzyl)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(3,4-difluorobenzyl)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(3,4-difluorobenzyl)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(2-phenylbenzyl)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(2-phenylbenzyl)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(3-Methoxycarbonylphenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(Hydroxymethyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(Hydroxymethyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(Phenoxymethyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(Phenoxymethyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(-hydroxybenzyl) phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4–hydroxybenzyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3–hydroxy-2-fluorobenzyl) phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(-Hydroxy-4-ethoxycarbonylbenzyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(-Hydroxy-3-ethoxycarbonylbenzyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(4-ethoxycarbonyl benzyl) phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(2-fluorobenzyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(-Fluorobenzyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(-Fluorobenzyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-Benzoylphenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-Benzoylphenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(1-Phenylvinyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(1-Phenylvinyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(-Methylbenzyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(-Methylbenzyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-Iodo-4-methylphenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(-Hydroxybenzyl)-4-methylphenyl)-N-ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-Benzyl-4-methylphenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(4-t-butylphenoxy)-4-methylphenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(2-Methoxyphenoxy)benzyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(2-Methoxyphenoxy)benzyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(2-Phenylvinyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(2-Phenylethyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(Prop-1-en-1-yl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(2-N,N-Diethylamidovinyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(2-Ethoxycarbonylvinyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-Propylphenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-Trifluoromethoxyphenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(3-trifluoromethoxyphenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-trifluoromethylphenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(4-trifluoromethoxyphenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-methoxyphenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(prop-2-yl)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(2-triflurormethoxyphenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(prop-2-yloxy)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(3-Benzyl-4-chlorophenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(3-Cyclobutyloxyphenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(3-isobutyloxyphenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(3-sec-butoxylphenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(3-cyclopentyloxyphenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(3-cyclohexyloxyphenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(1-ethoxycarbonyl-1,1-dimethyl, methoxy)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(1-ethoxycarbonyl-1-methylmethoxy)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(1-(ethoxycarbonyl)-cyclobut-1-yloxyphenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(3-pent-3-yloxyphenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(3-pent-2-yloxyphenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(2,2,2-trifluoroethoxy)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(2-methyl-butyloxy)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(ethoxycarbonyl, methoxy)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(2-Fluoro-4-cyanophenoxy)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(2-Fluoro-4-amidophenoxy)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(2-Fluoro-4-cyanophenoxy)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(2,4-Difluoro-4-cyanophenoxy)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(2-Fluoro-4-cyanophenoxy)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(2-Fluoro-4-amidophenoxy)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(Bromomethyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(2-Methoxybenzyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(2-trifluoromethyl, benzyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(4-cyanobenzyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(2-chlorobenzyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(4-fluorobenzyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(thien-2-yl methyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(thien-3-yl methyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(2-bromobenzyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(5-methyl-thiophen-2-yl)methyl phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(2,4-difluorobenzyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(2,4-dichlorobenzyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(1-(4-Bromophenyl)ethyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(4-Cyanophenyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-((2-Methoxy-5-phenyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(1-(4-Bromophenyl)ethyl)-N-(2,2,2-trifluroethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(4-Cyanophenyl)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine, N-((3-Iodophenyl)methyl)-N-(ethylsulfonyl)pyrid-3-ylamine, N-((3-Iodophenyl)methyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(1-(4-(2,4-Difluorophenyl)phenyl)ethyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(1-(4-(4-cyanophenyl)phenyl)ethyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-((3-(2,4-difluorophenyl)methyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(3-(4-cyanophenyl)phenyl)methyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(3-(3-methanesulfonylaminophenyl) phenyl)methyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(3-(4-N-methylamidophenyl)phenyl)methyl)-N-(ethylsulfonyl)pyrid-3-ylmethylamine, N-(1-(3-(4-cyanophenyl)phenyl)ethyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(2,4-difluorophenyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(4-N-methylamidophenyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-((3,5-bis-triflurormethyl)phenyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-((3-phenyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-((4-(2-trifluroacetylamino), ethyl)phenyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(4-acetylaminophenyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(4-methanephenylsulfonyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(4-trifluoromethoxyphenyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(pryid-4-yl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(3-trifluoromethylphenyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(4-carboxyphenyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(4-(N-methanesulfonyl-N-t-butoxycarbonylaminoethyl) phenyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(2-methylphenyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(2-methoxyphenyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(2-trifluoromethylphenyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(2-chlorophenyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(2-fluorophenyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(3,5-difluorophenyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(3-acetylaminophenyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-((4-Methyl-3-(4-cyanophenyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(4-(2-Methanesulfonylaminoethyl)phenyl)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)pyrid-3-ylmethylamine, N-((3-(4-Amidophenyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(3-(4-(2-Methanesulfonylaminoethyl)phenyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-((3-(2-Methyl-4-cyanophenyl)phenyl)-N-(ethanesulfonyl)pyrid-3-ylmethylamine, N-(4-(2,4-Difluorophenoxy)phenyl)-N-(ethanesulfonyl)-2-fluororpyrid-3-ylmethylamine, N-(4-(2,4-Difluorophenoxy)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)-2-fluororpyrid-3-ylmethylamine, N-(4-(2,4-Difluorophenoxy)phenyl)-N-(ethanesulfonyl)-6-fluororpyrid-3-ylmethylamine, N-(4-(2,4-Difluorophenoxy)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)-6-fluororpyrid-3-ylmethylamine, N-(4-(2,4-Difluorophenoxy)phenyl)-N-(ethanesulfonyl)-2-methylrpyrid-3-ylmethylamine, N-(4-(2,4-Difluorophenoxy)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)-2-methylrpyrid-3-ylmethylamine, N-(4-(2,4-Difluorophenoxy)phenyl)-N-(ethanesulfonyl)-6-methylrpyrid-3-ylmethylamine, N-(4-(2,4-Difluorophenoxy)phenyl)-N-(2,2,2-trifluoroethanesulfonyl)-6-methylrpyrid-3-ylmethylamine, and N-(3-(N-Methyl-N-(2-chlorophenylsulfonamido)phenyl))-N-(ethanesulfonyl)pyrid-3-ylmethylamine.
18. A pharmaceutical composition comprising a compound of claim 1 and a pharmaceutically acceptable diluent.
19. A method of treating neurological and psychiatric disorders associated with glutamate dysfunction, comprising: administering to a patient in need thereof an effective amount of a compound of claim 1.
20. A method of treating anxiety, comprising: administering to a patient in need thereof an effective amount of a compound of claim 1.
21. A method of treating migraine, comprising: administering to a patient in need thereof an effective amount of a compound of claim 1.
22. A method of treating schizophrenia, comprising: administering to a patient in need thereof an effective amount of a compound of claim 1.
23. A method of treating epilepsy, comprising: administering to a patient in need thereof an effective amount of a compound of claim 1.
24. The use of a compound of claim 1 as a medicament.
25. The use of a compound of claim 1 for the manufacture of a medicament for treating neurological and psychiatric disorders associated with glutamate dysfunction.
26. The use of a compound of claim 1 for the manufacture of a medicament for treating anxiety.
27. The use of a compound of claim 1 for the manufacture of a medicament for treating migraine.
28. The use of a compound of claim 1 for the manufacture of a medicament for treating schizophrenia.
29. The use of a compound of claim 1 for the manufacture of a medicament for treating epilepsy.
30. A method of treating neurological and psychiatric disorders associated with glutamate dysfunction, comprising: administering to a patient in need thereof an effective amount of an mGluR potentiator.
31. A method of treating anxiety, comprising: administering to a patient in need thereof an effective amount of a compound of an mGluR potentiator.
32. A method of treating migraine, comprising: administering to a patient in need thereof an effective amount of an mGluR potentiator.
33. A method of treating schizophrenia, comprising: administering to a patient in need thereof an effective amount of an mGluR potentiator.
34. A method of treating epilepsy, comprising: administering to a patient in need thereof an effective amount of an mGluR potentiator.
35. A method according to anyone of claims 30-34 wherein the mGluR potentiator is a mGluR2 potentiator.
36. A method according to anyone of claims 30-34 wherein the mGluR potentiator is a mGluR3 potentiator.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. An image forming apparatus comprising:
an image bearing body for bearing a latent image;
a plurality of attachdetach sections to each of which a developer container for containing developer used for developing said latent image can be attached; and
a container attachment mechanism for allowing
a developer container containing developer of a certain color to be attached to any of said plurality of attachdetach sections, and
a developer container containing developer of a color other than said certain color to be attached only to a predetermined attachdetach section of among said plurality of attachdetach sections.
2. An image forming apparatus according to claim 1, wherein:
said container attachment mechanism includes a plurality of openableclosable lid units, each of said lid units being connected to a respective one of said plurality of attachdetach sections and allowing said developer container to be attached to said attachdetach section by being closed; and
said lid unit closes when said developer container containing said developer of said certain color is inserted into any of said plurality of attachdetach sections, whereas said lid unit closes only when said developer container containing said developer of the color other than said certain color is inserted into said predetermined attachdetach section of among said plurality of attachdetach sections.
3. An image forming apparatus according to claim 2, wherein:
each of said developer container containing said developer of said certain color and developer containers that each contains developer of a color other than said certain color and different among each developer container, is provided with a projecting section;
said lid units connected to each of said plurality of attachdetach sections has a cut-out section for preventing said projecting section from interfering with that lid unit so that that lid unit will close; and
said lid unit closes when said developer container containing said developer of said certain color is inserted into any of said plurality of attachdetach sections due to said cut-out section preventing the interference, whereas said lid unit closes only when said developer container containing said developer of the color other than said certain color is inserted into said predetermined attachdetach section of among said plurality of attachdetach sections due to said cut-out section preventing the interference.
4. An image forming apparatus according to claim 3, wherein:
said plurality of attachdetach sections include attachdetach sections corresponding respectively to said developer containers each containing said developer of the respective colors other than said certain color;
the position of said projecting section provided on each of said developer containers is different among said developer container containing said developer of said certain color and said developer containers each containing said developer of the respective colors other than said certain color;
all of said lid units connected to said plurality of attachdetach sections each has a first cut-out section for preventing said projecting section provided on said developer container containing said developer of said certain color from interfering with that lid unit; and
the lid units connected to the attachdetach sections corresponding to said developer containers each containing said developer of the respective colors other than said certain color each has a second cut-out section for preventing said projecting section provided on each of those developer containers from interfering with that lid unit.
5. An image forming apparatus according to claim 4, wherein:
each of said developer containers each containing said developer of the respective colors other than said certain color has a second projecting section at a same position as said projecting section provided on said developer container containing said developer of said certain color.
6. An image forming apparatus according to claim 4, wherein:
each of said lid units has a connecting section that is connected to said attachdetach section, and is openableclosable taking said connecting section as an axis; and
a distance between said connecting section and said first cut-out section is larger than a distance between said connecting section and said second cut-out section.
7. An image forming apparatus according to claim 4, wherein:
said lid unit engages with and is fastened to said developer container at a fastening position when closed; and
a distance between said fastening position and said first cut-out section is smaller than a distance between said fastening position and said second cut-out section.
8. An image forming apparatus according to claim 1, wherein:
said developer container is a developing device provided with a developer bearing body for bearing the developer used for developing said latent image borne on said image bearing body.
9. An image forming apparatus according to claim 1, wherein:
said developer of said certain color is black developer.
10. An image forming apparatus comprising:
an image bearing body for bearing a latent image;
a plurality of attachdetach sections to each of which a developer container for containing developer used for developing said latent image can be attached; and
a container attachment mechanism for allowing
a developer container containing developer of a certain color to be attached to any of said plurality of attachdetach sections, and
a developer container containing developer of a color other than said certain color to be attached only to a predetermined attachdetach section of among said plurality of attachdetach sections;

wherein said container attachment mechanism includes a plurality of openableclosable lid units, each of said lid units being connected to a respective one of said plurality of attachdetach sections and allowing said developer container to be attached to said attachdetach section by being closed;
said lid unit closes when said developer container containing said developer of said certain color is inserted into any of said plurality of attachdetach sections, whereas said lid unit closes only when said developer container containing said developer of the color other than said certain color is inserted into said predetermined attachdetach section of among said plurality of attachdetach sections;
each of said developer container containing said developer of said certain color and developer containers that each contains developer of a color other than said certain color and different among each developer container, is provided with a projecting section;
said lid units connected to each of said plurality of attachdetach sections has a cut-out section for preventing said projecting section from interfering with that lid unit so that that lid unit will close;
said lid unit closes when said developer container containing said developer of said certain color is inserted into any of said plurality of attachdetach sections due to said cut-out section preventing the interference, whereas said lid unit closes only when said developer container containing said developer of the color other than said certain color is inserted into said predetermined attachdetach section of among said plurality of attachdetach sections due to said cut-out section preventing the interference;
said plurality of attachdetach sections include attachdetach sections corresponding respectively to said developer containers each containing said developer of the respective colors other than said certain color;
the position of said projecting section provided on each of said developer containers is different among said developer container containing said developer of said certain color and said developer containers each containing said developer of the respective colors other than said certain color;
all of said lid units connected to said plurality of attachdetach sections each has a first cut-out section for preventing said projecting section provided on said developer container containing said developer of said certain color from interfering with that lid unit;
the lid units connected to the attachdetach sections corresponding to said developer containers each containing said developer of the respective colors other than said certain color each has a second cut-out section for preventing said projecting section provided on each of those developer containers from interfering with that lid unit;
each of said developer containers each containing said developer of the respective colors other than said certain color has a second projecting section at a same position as said projecting section provided on said developer container containing said developer of said certain color;
each of said lid units has a connecting section that is connected to said attachdetach section, and is openableclosable taking said connecting section as an axis;
a distance between said connecting section and said first cut-out section is larger than a distance between said connecting section and said second cut-out section;
said lid unit engages with and is fastened to said developer container at a fastening position when closed;
a distance between said fastening position and said first cut-out section is smaller than a distance between said fastening position and said second cut-out section;
said developer container is a developing device provided with a developer bearing body for bearing the developer used for developing said latent image borne on said image bearing body; and
said developer of said certain color is black developer.
11. An image forming system comprising:
a computer; and
an image forming apparatus that is connectable to said computer and that includes:
an image bearing body for bearing a latent image;
a plurality of attachdetach sections to each of which a developer container for containing developer used for developing said latent image can be attached; and
a container attachment mechanism for allowing
a developer container containing developer of a certain color to be attached to any of said plurality of attachdetach sections, and
a developer container containing developer of a color other than said certain color to be attached only to a predetermined attachdetach section of among said plurality of attachdetach sections.
12. An image forming apparatus comprising:
an image bearing body for bearing a latent image;
an attachdetach section to which a developer container for containing developer used for developing said latent image can be attached; and
a lid unit that covers a portion of said developer container attached to said attachdetach section and whose color is different from a color of said developer container at a boundary section between said lid unit and said developer container.
13. An image forming apparatus according to claim 12, wherein:
said lid unit covers a portion of a side wall of said developer container attached to said attachdetach section, and the color of said lid unit is different from a color of said side wall at a boundary section between said lid unit and said side wall.
14. An image forming apparatus according to claim 13, wherein:
said side wall is provided with a handle; and
said portion of said side wall covered by said lid unit is a portion other than said handle.
15. An image forming apparatus according to claim 13, wherein:
said lid unit has a lid member that covers said portion of said side wall, said lid member having a connecting section that is connected to said attachdetach section and being openableclosable taking said connecting section as an axis;
said boundary section is a portion of said lid member; and
a color of said lid member is different from said color of said side wall.
16. An image forming apparatus according to claim 15, wherein:
a member having a same color as said color of said side wall is supported on a back side of said lid member.
17. An image forming apparatus according to claim 15, wherein:
said lid unit has a holding member for holding said lid member in a closed state; and
said holding member is said member having the same color as said color of said side wall.
18. An image forming apparatus according to claim 17, wherein:
said lid unit has an operation member that is connected to said holding member for operating said holding member.
19. An image forming apparatus according to claim 18, wherein:
a color of said operation member is different from said color of said side wall.
20. An image forming apparatus according to claim 12, wherein:
there are a plurality of attachdetach sections.
21. An image forming apparatus according to claim 12, wherein:
said developer container is a developing device provided with a developer bearing body for bearing the developer used for developing said latent image borne on said image bearing body.
22. An image forming apparatus comprising:
an image bearing body for bearing a latent image;
an attachdetach section to which a developer container for containing developer used for developing said latent image can be attached; and
a lid unit that covers a portion of said developer container attached to said attachdetach section and whose color is different from a color of said developer container at a boundary section between said lid unit and said developer container;
wherein said lid unit covers a portion of a side wall of said developer container attached to said attachdetach section, and the color of said lid unit is different from a color of said side wall at a boundary section between said lid unit and said side wall;
said side wall is provided with a handle;
said portion of said side wall covered by said lid unit is a portion other than said handle;
said lid unit has a lid member that covers said portion of said side wall, said lid member having a connecting section that is connected to said attachdetach section and being openableclosable taking said connecting section as an axis;
said boundary section is a portion of said lid member;
a color of said lid member is different from said color of said side wall;
a member having a same color as said color of said side wall is supported on a back side of said lid member;
said lid unit has a holding member for holding said lid member in a closed state;
said holding member is said member having the same color as said color of said side wall;
said lid unit has an operation member that is connected to said holding member for operating said holding member;
a color of said operation member is different from said color of said side wall;
there are a plurality of attachdetach sections; and
said developer container is a developing device provided with a developer bearing body for bearing the developer used for developing said latent image borne on said image bearing body.
23. An image forming system comprising:
a computer; and
an image forming apparatus that is connectable to said computer and that includes:
an image bearing body for bearing a latent image;
an attachdetach section to which a developer container for containing developer used for developing said latent image can be attached; and
a lid unit that covers a portion of said developer container attached to said attachdetach section and whose color is different from a color of said developer container at a boundary section between said lid unit and said developer container.
24. An image forming apparatus comprising:
(a) an image bearing body for bearing a latent image;
(b) an attachdetach section to which a developer container for containing developer used for developing said latent image can be attached; and
(c) a lid body that is connected to said attachdetach section in a turnable fashion about a turn axis, said lid body being provided with engaging sections for engaging with said developer container, at least one of said engaging sections being provided on a side closer to said turn axis and at least one of said engaging section being provided on a side farther from said turn axis, said lid body being able to close said attachdetach section when a developer container that should be attached is attached to said attachdetach section due to all of said engaging sections being engaged with said developer container, whereas said lid body being unable to close said attachdetach section when a developer container that should not be attached is attached to said attachdetach section due to one of said engaging sections not being engaged with said developer container.
25. An image forming apparatus according to claim 24, wherein:
a timing at which the at least one engaging section on the closer side starts engaging with said developer container is different from a timing at which the at least one engaging section on the farther side starts engaging with said developer container.
26. An image forming apparatus according to claim 25, wherein:
of among the at least one engaging section on the closer side and the at least one engaging section on the farther side, the engaging section that engages with said developer container first restricts a behavior of said lid body when the other engaging section engages with said developer container afterward.
27. An image forming apparatus according to claim 24, wherein:
the at least one engaging section on the closer side and the at least one engaging section on the farther side are aligned in a direction that intersects with said turn axis.
28. An image forming apparatus according to claim 24, wherein:
said developer container has at least two shaped information sections that indicate information about that developer container with a predetermined outer shape; and
said engaging sections engage with said shaped information sections.
29. An image forming apparatus according to claim 28, wherein:
a piece of information about said developer container is distinguishable by the at least one engaging section on the closer side and the at least one engaging section on the farther side respectively engaging with said at least two shaped information sections.
30. An image forming apparatus according to claim 28, wherein:
a piece of information about said developer container is distinguishable by one of the at least one engaging section on the closer side and the at least one engaging section on the farther side engaging with one of said at least two shaped information sections.
31. An image forming apparatus according to claim 28, wherein:
said information is information indicative of a color of the developer contained in said developer container.
32. An image forming apparatus according to claim 28, wherein:
said information is information indicative of a destination of the developer contained in said developer container.
33. An image forming apparatus according to claim 24, wherein:
there are a plurality of attachdetach sections; and
said lid body is provided for each of said attachdetach sections.
34. An image forming apparatus comprising:
(a) an image bearing body for bearing a latent image;
(b) an attachdetach section to which a developer container for containing developer used for developing said latent image can be attached; and
(c) a lid body that is connected to said attachdetach section in a turnable fashion about a turn axis, said lid body being provided with engaging sections for engaging with said developer container, at least one of said engaging sections being provided on a side closer to said turn axis and at least one of said engaging section being provided on a side farther from said turn axis, said lid body being able to close said attachdetach section when a developer container that should be attached is attached to said attachdetach section due to all of said engaging sections being engaged with said developer container, whereas said lid body being unable to close said attachdetach section when a developer container that should not be attached is attached to said attachdetach section due to one of said engaging sections not being engaged with said developer container;
wherein the at least one engaging section on the closer side and the at least one engaging section on the farther side are aligned in a direction that intersects with said turn axis;
a timing at which the at least one engaging section on the closer side starts engaging with said developer container is different from a timing at which the at least one engaging section on the farther side starts engaging with said developer container;
of among the at least one engaging section on the closer side and the at least one engaging section on the farther side, the engaging section that engages with said developer container first restricts a behavior of said lid body when the other engaging section engages with said developer container afterward;
said developer container has at least two shaped information sections that indicate information about that developer container with a predetermined outer shape;
said engaging sections engage with said shaped information sections;
a piece of information about said developer container is distinguishable by the at least one engaging section on the closer side and the at least one engaging section on the farther side respectively engaging with said at least two shaped information sections;
a piece of information about said developer container is distinguishable by one of the at least one engaging section on the closer side and the at least one engaging section on the farther side engaging with one of said at least two shaped information sections;
said information is information indicative of a color of the developer contained in said developer container;
said information is information indicative of a destination of the developer contained in said developer container;
there are a plurality of attachdetach sections; and
said lid body is provided for each of said attachdetach sections.
35. An image forming system comprising:
(A) a computer; and
(B) an image forming apparatus that is connectable to said computer and that includes the following elements (a) through (c):
(a) an image bearing body for bearing a latent image;
(b) an attachdetach section to which a developer container for containing developer used for developing said latent image can be attached; and
(c) a lid body that is connected to said attachdetach section in a turnable fashion about a turn axis, said lid body being provided with engaging sections for engaging with said developer container, at least one of said engaging sections being provided on a side closer to said turn axis and at least one of said engaging section being provided on a side farther from said turn axis, said lid body being able to close said attachdetach section when a developer container that should be attached is attached to said attachdetach section due to all of said engaging sections being engaged with said developer container, whereas said lid body being unable to close said attachdetach section when a developer container that should not be attached is attached to said attachdetach section due to one of said engaging sections not being engaged with said developer container.